A partnership aims to integrate machine learning methods into Additive Manufacturing (AM) workflows to accelerate the development of reliable and repeatable processes
Optibrium, Intellegens and Medicines Discovery Catapult have announced that they have been awarded a £1 million grant from Innovate UK to support the development of artificical Intelligence (AI) in drug discovery
Intellegens, a new company spun out of the University of Cambridge to develop and commercialise novel artificial intelligence (AI) software, has received funding from Cambridge Enterprise and local angel investor Graham Snudden
Things are hotting up in the world of weather and climate forecasting thanks to today’s highly ambitious projects
Drug discovery is a complex process that requires increasing resources and time to generate new molecules. As the processes have matured there is an increasing reliance on computational methods to accelerate the discovery process.
Patients across the UK will benefit from better healthcare, treatments and faster diagnosis as the government sets out plans to deliver genomic healthcare
One of the most obvious, and immediate challenges when bringing new software into a lab environment is the likely ‘spaghetti soup’ of existing platforms – possibly from multiple vendors – that are already installed, suggests Richard Milne
With the growth of AI and DL comes new opportunities for emerging applications finds Robert Roe
Robert Roe takes a look at the training and skills development opportunities for scientists using HPC in their research
A round-up of the latest cooling technologies for scientists using HPC to support their research
A round-up of the latest storage products and technology available for scientists using HPC as a tool for their research
